AnalystsAdam VogelAdam Vogel's Stock Forecasts
AnalystsAdam Vogel
Sectors:
Industries:
Analyst Ranking
Top 40%
#2120 out of 5298 analysts
Average Return
+18.84%
Win Rate
50%3 out of 6
Risk vs Reward
Poor
Good
Adam Vogel's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunome IncIMNM | +70.25% | $10.52 | $17.91 | 2025-09-04 - 2026-06-16 | Buy |
Apogee Therapeutics IncAPGE | +56.84% | $54.35 | $85.24 | 2025-11-02 - 2026-06-16 | Buy |
Lb Pharmaceuticals IncLBRX | +13.64% | $24.34 | $27.66 | 2026-04-09 - 2026-06-16 | Buy |
Pepgen IncPEPG | 0.00% | $1.59 | $1.59 | 2026-06-15 - 2026-06-16 | Buy |
Adam Vogel Analyst Color
Get additional color on Adam Vogel's coverage of popular stocks
Adam Vogel's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pepgen IncPEPG | 1 | Buy | $11.00 | +591.82% | Initiates Coverage On | a day ago |
Maplight Therapeutics IncMPLT | 1 | Buy | $43.00 | +58.32% | Initiates Coverage On | a month ago |
Lb Pharmaceuticals IncLBRX | 1 | Buy | $36.00 | +30.15% | Initiates Coverage On | 2 months ago |
Immunome IncIMNM | 2 | Buy | $36.00 | +101.01% | Maintains | 3 months ago |
Apogee Therapeutics IncAPGE | 1 | Buy | $109.00 | +27.87% | Initiates Coverage On | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.